A Cohort Study of the Prognostic Impact of Exon-16 EZH2 Mutations in a Mexican-Mestizo Population of Patients with Diffuse Large B-Cell Lymphoma
Background: Novel prognostic factors in patients with diffuse large B-cell lymphoma (DLBCL) are required in the era of Rituximab. Objective: The objective of the study was to study the prognostic impact of exon-16 enhancer-of-zeste homolog-2 (EZH2) mutations in patients with DLBCL. Methods: In a coh...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2021-01-01
|
Series: | Revista de Investigación Clínica |
Subjects: | |
Online Access: | https://www.clinicalandtranslationalinvestigation.com/frame_esp.php?id=377 |